Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Ponpipom

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|January 1, 1987
Structure-activity relationships of kadsurenone analoguesM M Ponpipom, R L Bugianesi, D R Brooker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1981
Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophagesJ C Robbins, M H Lam, C S Tripp, et al.
International Journal of Immunopharmacology|January 1, 1990
Steroidal glycolipid, L-644,257, is a potent enhancer of nonspecific host resistanceW K Hagmann, M M Ponpipom, J J Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.
Journal of Medicinal Chemistry|February 1, 1990
Glycolipids as host resistance stimulatorsM M Ponpipom, W K Hagmann, L A O'Grady, et al.
Journal of Medicinal Chemistry|September 1, 1978
Structure-activity relationships of aminoalkyl and -aryl glycosides having insulin-like activityP L Durette, R L Bugianesi, M M Ponpipom, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Stability of carbohydrate-modified vesicles in vivo: comparative effects of ceramide and cholesterol glycoconjugatesP S Wu, H M Wu, G W Tin, et al.
Biochemical Medicine|October 1, 1985
Targeting of synthetically glycosylated human placental glucocerebrosidaseG J Murray, T W Doebber, T Y Shen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|January 1, 1987
Structure-activity relationships of kadsurenone analoguesM M Ponpipom, R L Bugianesi, D R Brooker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1981
Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophagesJ C Robbins, M H Lam, C S Tripp, et al.
International Journal of Immunopharmacology|January 1, 1990
Steroidal glycolipid, L-644,257, is a potent enhancer of nonspecific host resistanceW K Hagmann, M M Ponpipom, J J Jackson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.
Journal of Medicinal Chemistry|February 1, 1990
Glycolipids as host resistance stimulatorsM M Ponpipom, W K Hagmann, L A O'Grady, et al.
Journal of Medicinal Chemistry|September 1, 1978
Structure-activity relationships of aminoalkyl and -aryl glycosides having insulin-like activityP L Durette, R L Bugianesi, M M Ponpipom, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Stability of carbohydrate-modified vesicles in vivo: comparative effects of ceramide and cholesterol glycoconjugatesP S Wu, H M Wu, G W Tin, et al.
Biochemical Medicine|October 1, 1985
Targeting of synthetically glycosylated human placental glucocerebrosidaseG J Murray, T W Doebber, T Y Shen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Pageof 3